302 related articles for article (PubMed ID: 31679275)
1. Evaluation of LncRNA ANRIL Potential in Hepatic Cancer Progression.
Ji Y; Sun H; Liang H; Wang Y; Lu M; Guo Z; Lv Z; Ren W
J Environ Pathol Toxicol Oncol; 2019; 38(2):119-131. PubMed ID: 31679275
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
Ma J; Li T; Han X; Yuan H
J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
[TBL] [Abstract][Full Text] [Related]
3. The long noncoding RNA NEAT1 contributes to hepatocellular carcinoma development by sponging miR-485 and enhancing the expression of the STAT3.
Zhang XN; Zhou J; Lu XJ
J Cell Physiol; 2018 Sep; 233(9):6733-6741. PubMed ID: 29219178
[TBL] [Abstract][Full Text] [Related]
4. Knockdown long non-coding RNA ANRIL inhibits proliferation, migration and invasion of HepG2 cells by down-regulation of miR-191.
Huang D; Bi C; Zhao Q; Ding X; Bian C; Wang H; Wang T; Liu H
BMC Cancer; 2018 Sep; 18(1):919. PubMed ID: 30249208
[TBL] [Abstract][Full Text] [Related]
5. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis.
Wang YG; Liu J; Shi M; Chen FX
J Cell Physiol; 2018 Jan; 234(1):572-580. PubMed ID: 30216442
[TBL] [Abstract][Full Text] [Related]
6. LINC01433 promotes hepatocellular carcinoma progression via modulating the miR-1301/STAT3 axis.
Huang H; Bu YZ; Zhang XY; Liu J; Zhu LY; Fang Y
J Cell Physiol; 2019 May; 234(5):6116-6124. PubMed ID: 30317567
[TBL] [Abstract][Full Text] [Related]
7. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma.
Lv J; Kong Y; Gao Z; Liu Y; Zhu P; Yu Z
Int J Biochem Cell Biol; 2018 Aug; 101():19-28. PubMed ID: 29791864
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
Zhou Q; Zhang W; Wang Z; Liu S
BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA TPTEP1 inhibits hepatocellular carcinoma progression by suppressing STAT3 phosphorylation.
Ding H; Liu J; Zou R; Cheng P; Su Y
J Exp Clin Cancer Res; 2019 May; 38(1):189. PubMed ID: 31072375
[TBL] [Abstract][Full Text] [Related]
11. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
12. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
[TBL] [Abstract][Full Text] [Related]
14. LncRNA CRNDE promotes hepatocellular carcinoma cell proliferation, invasion, and migration through regulating miR-203/ BCAT1 axis.
Ji D; Jiang C; Zhang L; Liang N; Jiang T; Yang B; Liang H
J Cell Physiol; 2019 May; 234(5):6548-6560. PubMed ID: 30230527
[TBL] [Abstract][Full Text] [Related]
15. LINC00339 regulates ROCK1 by miR-152 to promote cell proliferation and migration in hepatocellular carcinoma.
Chen K; Zhang L
J Cell Biochem; 2019 Sep; 120(9):14431-14443. PubMed ID: 31081143
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA TINCR promotes hepatocellular carcinoma proliferation and invasion via STAT3 signaling by direct interacting with T-cell protein tyrosine phosphatase (TCPTP).
Tang C; Feng W; Bao Y; Du H
Bioengineered; 2021 Dec; 12(1):2119-2131. PubMed ID: 34057016
[TBL] [Abstract][Full Text] [Related]
17. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
Dong H; Jian P; Yu M; Wang L
J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
[TBL] [Abstract][Full Text] [Related]
18. LINC00174 is an oncogenic lncRNA of hepatocellular carcinoma and regulates miR-320/S100A10 axis.
Zhao JT; Chi BJ; Sun Y; Chi NN; Zhang XM; Sun JB; Chen Y; Xia Y
Cell Biochem Funct; 2020 Oct; 38(7):859-869. PubMed ID: 32128852
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
[TBL] [Abstract][Full Text] [Related]
20. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
Huang B; Huang M; Li Q
Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
